M&M Pharmasp. z o.o.

Retail sale of medical and orthopaedic goods in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-02-28
Share capital
30,000.00 PLN
Registered address
Solipska 33/50, 02-482 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2024, 45 days late).

  • 202503/07/2026
  • 202429/08/2025
  • 202312/07/2024
  • 202207/07/2023
  • 202113/07/2022
  • 202030/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 476.50kMedianUSD 344.45kAverageUSD 2.51m
Net profit
This companyUSD 63.53kMedianUSD 14.78kAverageUSD 165.71k
Operating costs
This companyUSD 403.32kMedianUSD 298.04kAverageUSD 2.27m
Assets
This companyUSD 202.87kMedianUSD 201.82kAverageUSD 1.23m

Industry

Authorized Representatives

Agata Brodziak Czerny – President of the Management Board
Kamila Agnieszka Chwiłoc – Management Board Member
Marzena Stanisława Dziki – Management Board Member

Manner of representation

In the case of a one-person management board – a member of the management board acting independently. In the case of a multi-member management board – two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Agata Weronika Brodziak Czernyage 51
69$1,863.8623%
Kamila Agnieszka Chwiłocage 47
69$1,863.8623%
Marek Dzikiage 63
54$1,458.6718%
Marzena Stanisława Dzikiage 59
90$2,431.1230%
Others
18$486.226%

Beneficial owners

Person

Subsidiaries

NameStake
50%

Bank accounts

Registered as a VAT taxpayer on 2014-04-03.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$847

Competitors

Name
Medico Systemssp. z o.o.
Gaminesp. z o.o.
Medinedsp. z o.o.
Lumamedsp. z o.o.
Medical Smart Integratorsp. z o.o.
Orto-Vinci Warszawasp. z o.o.
Oneopticsp. z o.o.
Estetic Fillerssp. z o.o.
Quadro Pharmsp. z o.o.
Zakład Optyczny Zdzisław Robaksp. j.

Change history

DateEvent
2016-04-12PKD change
2014-02-28Entered in the register

FAQ

Last updated: 2026-07-06